One‐Week Once‐Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin
Article
Miehlke, Stephan, Schneider‐Brachert, Wulf, Kirsch, Christian, Morgner, Andrea, Madisch, Ahmed, Kuhlisch, Eberhard, Haferland, Christian, Bästlein, Elke, Jebens, Claus, Zekorn, Christian, Knoth, Holger, Stolte, Manfred and Lehn, Norbert (2008) One‐Week Once‐Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin. Helicobacter 13 (1), pp. 69-74.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Helicobacter | ||||
| Publisher | WILEY | ||||
| Place of Publication | HOBOKEN | ||||
| Volume | 13 | ||||
| Number of Issue or Book Chapter | 1 | ||||
| Page Range | pp. 69-74 | ||||
| Date | 2008 | ||||
| Date of publication | 19 Dec 2024 13:23 | ||||
| Institutions | Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene | ||||
| Identification Number |
| ||||
| Keywords | DOSE DUAL THERAPY; 2ND-LINE TREATMENT; QUADRUPLE THERAPY; 1ST-LINE TREATMENT; TREATMENT FAILURE; RANDOMIZED-TRIAL; INFECTION; LEVOFLOXACIN; METAANALYSIS; PREVALENCE; Helicobacter pylori; moxifloxacin; levofloxacin; fluoroquinolones; rifabutin; esomeprazole; metronidazole; clarithromycin; resistance; CYP2C19 polymorphism | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 68419 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric